Financial Performance - The company achieved a net profit of ¥9,529,007,857.85 for the year 2022, with a total distributable profit of ¥20,193,062,014.56 after accounting for retained earnings[3]. - The company's operating revenue for 2022 was approximately ¥122.70 billion, an increase of 11.40% compared to ¥110.14 billion in 2021[13]. - Net profit attributable to shareholders for 2022 was approximately ¥9.43 billion, reflecting an 8.34% increase from ¥8.70 billion in 2021[13]. - The company achieved total revenue of CNY 123.171 billion, a year-on-year increase of 11.37%, and a net profit of CNY 9.318 billion, up 6.71% from the previous year[28]. - The company reported a net profit margin of approximately 8.8% for 2022, slightly down from 9.3% in 2021[194]. - The total revenue for the year was 6,439.2356 million CNY, with no change in shareholding for the board members[87]. - The company reported a total comprehensive income of ¥9,462,126,281.23 for 2022, up from ¥8,376,267,735.75 in 2021[198]. Dividends and Share Capital - A cash dividend of ¥10.40 per 10 shares (including tax) is proposed, amounting to a total of ¥6,631,374,785.36, which represents 70.31% of the net profit attributable to shareholders[3]. - The total cash dividend amount (including tax) is 6,934,493,429.94 RMB, which accounts for 73.53% of the net profit attributable to ordinary shareholders in the consolidated financial statements[107]. - The total share capital as of March 31, 2023, is 6,398,918,718 shares, after deducting 22,596,809 shares held in the repurchase account[3]. - The company maintained a consistent shareholding of 472,027,056 shares throughout the year[87]. - The company repurchased and canceled 785,600 restricted shares as part of the 2019 stock incentive plan, resulting in a total share capital of 6,399,345,318 shares[160]. Assets and Liabilities - The total assets at the end of 2022 reached approximately ¥130.97 billion, marking a significant increase of 28.44% from ¥101.96 billion at the end of 2021[13]. - Total liabilities increased to CNY 76.82 billion in 2022, up from CNY 53.17 billion in 2021, representing a growth of 44.4%[191]. - The company's total equity attributable to shareholders reached CNY 50.27 billion in 2022, up from CNY 47.71 billion in 2021, indicating a growth of 5.3%[191]. - The company's goodwill increased significantly to CNY 4.95 billion from CNY 306.29 million, indicating a substantial investment in acquisitions[190]. - The company's debt-to-asset ratio increased to 58.66%, up 12.48% from 52.15% in 2021[183]. Cash Flow - The net cash flow from operating activities decreased by 13.57% to approximately ¥13.42 billion, down from ¥15.53 billion in 2021[13]. - The cash inflow from operating activities was approximately ¥137.82 billion, an increase of 10.9% from ¥124.25 billion in 2021[199]. - The cash outflow for investment activities surged to approximately ¥21.00 billion, compared to ¥8.18 billion in the previous year, indicating a rise of 156.5%[200]. - The net cash flow from investment activities was negative at approximately -¥19.51 billion, worsening from -¥7.80 billion in 2021[200]. Research and Development - The company’s R&D expenses increased by 36.69% to CNY 821.55 million, up from CNY 601.02 million in the previous year[36]. - The company is focused on enhancing its innovation capabilities, having received 76 domestic and international technology innovation awards during the reporting period[31]. - Research and development expenses increased to ¥646,093,606.80, compared to ¥543,192,049.39 in the previous year, reflecting a focus on innovation[198]. Market Position and Growth - The company's liquid dairy product retail market share is 33.4%, maintaining the leading position in the segment[22]. - The company’s overseas business revenue grew by 52.2% compared to 2021, reflecting successful international expansion[25]. - The company has seen a 20% increase in high-growth businesses such as organic dairy and plant-based nutrition products compared to 2021[24]. - The company is focusing on expanding its market presence and enhancing product development strategies to drive future growth[188]. Governance and Compliance - The company has established a clear governance structure to protect the rights of all shareholders, particularly minority shareholders[81]. - The company strictly adheres to information disclosure regulations, ensuring that all shareholders have equal access to information[83]. - The company has not reported any changes in shareholding among its directors and supervisors during the reporting period[87]. - The company has implemented a comprehensive internal control system, enhancing management efficiency and ensuring compliance with legal regulations[111]. Environmental and Social Responsibility - The company invested a total of CNY 203.91 million in environmental protection facilities in 2022, focusing on wastewater treatment facility upgrades and online monitoring equipment[124]. - The company achieved a reduction of 21,000 tons of sludge in 2022 by converting 27 wastewater treatment systems to a biological membrane method, with 25 systems achieving zero sludge operation[130]. - The company has committed to sustainable development and green management, continuously upgrading its green initiatives and actions[136]. - The company donated a total of 10,484.49 million RMB in cash and materials in response to major disaster events during the reporting period[143]. Future Outlook - The company plans to achieve a total revenue of 135.5 billion RMB and a total profit of 12.5 billion RMB in 2023, subject to market uncertainties[78]. - The company aims to invest 8.73 billion RMB in leading industry projects and supporting projects in 2023, with funding sourced from self-raised funds, bank loans, and other financing methods[79]. - Future strategies include expanding production capacity and enhancing product quality through technological advancements[120].

Financial Performance - The company's operating revenue for Q1 2023 was CNY 33,328,470,170.19, representing a year-on-year increase of 7.81%[4] - The net profit attributable to shareholders for Q1 2023 was CNY 3,615,021,381.48, reflecting a year-on-year growth of 2.73%[4] - Basic earnings per share for Q1 2023 were CNY 0.57, an increase of 1.79% year-on-year[4] - Total operating revenue for Q1 2023 reached RMB 33.44 billion, a 7.7% increase from RMB 31.05 billion in Q1 2022[12] - Net profit for Q1 2023 was RMB 3.62 billion, up from RMB 3.51 billion in Q1 2022, representing a 3.1% increase[13] - The total comprehensive income for Q1 2023 was RMB 3.56 billion, compared to RMB 3.42 billion in Q1 2022, indicating a 4.1% increase[13] Cash Flow - The net cash flow from operating activities increased significantly by 190.25% to CNY 1,281,223,901.40 compared to the same period last year[6] - Cash flow from operating activities generated RMB 1.28 billion in Q1 2023, significantly higher than RMB 441.42 million in Q1 2022[14] - The cash flow from operating activities for Q1 2023 was CNY 12,428,825,542.51, a significant improvement from a negative cash flow of CNY -72,511,756.54 in Q1 2022[19] - The net increase in cash and cash equivalents for Q1 2023 was 9,233,452,185.11 CNY, compared to 5,958,354,414.38 CNY in the same quarter last year, indicating improved liquidity[15] Assets and Liabilities - The total assets at the end of Q1 2023 reached CNY 147,254,217,870.79, marking a 12.44% increase from the end of the previous year[4] - Total liabilities increased to RMB 89,675,462,646.78, compared to RMB 76,822,199,099.56 at the end of 2022, marking a rise of 16.5%[11] - The company's total assets amounted to RMB 147,254,217,870.79, an increase of 12.4% from RMB 130,965,302,299.22 at the end of 2022[11] - The total liabilities as of Q1 2023 were 66,504,302,525.38 CNY, up from 54,380,044,549.66 CNY in the previous year, indicating a rise in financial obligations[17] - The company's short-term borrowings increased significantly to 10,563,370,972.20 CNY from 5,560,487,500.01 CNY year-over-year, reflecting a strategy to leverage more debt[17] Equity - The equity attributable to shareholders increased by 6.45% to CNY 53,509,313,084.13 compared to the end of the previous year[4] - The total equity attributable to shareholders reached RMB 53,509,313,084.13, up from RMB 50,267,883,832.15, indicating a growth of 4.5%[11] - The company's retained earnings rose to 25,451,038,877.26 CNY in Q1 2023, up from 20,193,062,014.56 CNY in Q1 2022, reflecting strong profit retention[17] Research and Development - Research and development expenses increased to RMB 149.70 million in Q1 2023, compared to RMB 115.76 million in Q1 2022, marking a 29.3% rise[12] - Research and development expenses for Q1 2023 were CNY 124,525,209.58, up from CNY 106,037,768.46 in Q1 2022, reflecting a focus on innovation[18] Operational Efficiency - The company reported a decrease in the weighted average return on equity, indicating potential challenges in maintaining profitability[4] - The company reported a decrease in tax expenses to RMB 645.09 million in Q1 2023 from RMB 595.58 million in Q1 2022, a reduction of 8.3%[13] - The company reported a decrease in accounts receivable to RMB 2,864,538,385.10 from RMB 3,088,345,121.78, a decline of 7.3%[10] - The company reported a decrease in sales expenses to CNY 4,894,239,508.58 from CNY 5,286,167,039.20 in Q1 2022, indicating improved cost management[18] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[6] - The company has adopted new accounting standards effective from January 1, 2023, impacting the presentation of financial statements[20]

证券代码：600887 证券简称：伊利股份 公告编号：临 2023-025 内蒙古伊利实业集团股份有限公司关于召开 2022 年度暨 2023 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 内蒙古伊利实业集团股份有限公司（简称"公司"）将于 2023 年 4 月 28 日发布公司 2022 年年度报告及 2023 年第一季度报告。为便于广 大投资者更全面、深入地了解公司经营成果、财务状况，公司计划于 2023 年 4 月 28 日举行 2022 年度暨 2023 年第一季度业绩说明会，就投 资者普遍关注的问题进行交流。 一、说明会类型 本次业绩说明会将采取两种方式召开，分别为电话会议及上证路 演中心音频直播结合网络互动，公司将针对 2022 年度及 2023 年第一 季度的经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 1 二、说明会召开的方式、时间 重要内容提示： 会议召开方式： 1、电话会议 2、上证路演中心音频直播结合网络互动 ...

Financial Performance - The company's revenue for Q3 2022 reached ¥30,286,813,946.99, representing a year-on-year increase of 6.72%[3] - Net profit attributable to shareholders decreased by 26.46% to ¥1,928,539,634.85 in Q3 2022[3] - The net profit excluding non-recurring gains and losses fell by 33.27% to ¥1,692,818,530.48 for the same period[3] - Basic earnings per share decreased by 31.82% to ¥0.30, while diluted earnings per share also dropped by 30.23%[3] - The weighted average return on equity decreased by 3.78 percentage points to 4.08% in Q3 2022[3] - Total operating revenue for the first three quarters of 2022 reached ¥93.86 billion, an increase of 10.8% compared to ¥85.01 billion in the same period of 2021[13] - Operating profit for the first three quarters of 2022 was ¥9.55 billion, slightly up from ¥9.41 billion in the previous year, reflecting a growth of 1.5%[13] - The net profit margin for the first three quarters of 2022 was approximately 9.9%, consistent with the previous year's margin[13] - The company's retained earnings reached ¥26.22 billion in Q3 2022, up from ¥24.30 billion in Q3 2021, showing an increase of 7.9%[12] - The total comprehensive income attributable to the parent company's owners for Q3 2022 was CNY 5,949,396,584.66, down from CNY 7,934,188,008.33 in Q3 2021, a decline of approximately 25.0%[14] Assets and Liabilities - Total assets increased by 22.88% to ¥125,294,687,165.68 compared to the end of the previous year[3] - The company's total assets reached ¥125.29 billion in Q3 2022, up from ¥101.96 billion in Q3 2021, indicating a growth of 22.8%[12] - Total liabilities as of the end of Q3 2022 amounted to ¥73.26 billion, compared to ¥53.17 billion at the end of Q3 2021, representing a growth of 37.7%[12] - The company's short-term borrowings increased to ¥28.72 billion in Q3 2022, compared to ¥12.60 billion in Q3 2021, reflecting a significant rise of 128.5%[12] - The company's total equity reached CNY 41.63 billion, compared to CNY 38.59 billion in the previous year, reflecting an increase of about 7.9%[20] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥8,874,706,465.42, down 28.54% year-on-year[3] - The net cash flow from operating activities for the first nine months of 2022 was CNY 8,874,706,465.42, down from CNY 12,418,665,061.72 in the previous year, a decrease of approximately 28.8%[16] - The net cash flow from financing activities was CNY 11,104,386,152.82 in the first nine months of 2022, a significant improvement from CNY -914,189,107.34 in the same period of 2021[17] - The cash and cash equivalents at the end of Q3 2022 amounted to CNY 39,110,051,524.71, an increase from CNY 17,177,740,114.29 at the end of Q3 2021, representing a growth of approximately 128.5%[17] Shareholder Information - The number of common shareholders at the end of the reporting period was 480,896[6] - The top ten shareholders held a combined 40.27% of the total shares, with Hong Kong Central Clearing Limited being the largest shareholder at 18.14%[6] - The company reported a total of 2.86 billion shares outstanding, with 1.16 billion shares held by the largest shareholder[6] Research and Development - Research and development expenses increased to ¥532.54 million in 2022, up from ¥402.46 million in 2021, marking a rise of 32.3%[13] - Research and development expenses for the first three quarters of 2022 were ¥405.13 million, a slight increase from ¥366.13 million in the same period of 2021[21] Market Strategy - The increase in sales expenses due to intensified market competition contributed to the decline in net profit[5] - The company plans to continue focusing on market expansion and product innovation to enhance competitiveness in the future[5]

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 63.21 billion, an increase of 12.29% compared to CNY 56.29 billion in the same period last year[9]. - The net profit attributable to shareholders for the first half of 2022 was CNY 6.13 billion, reflecting a growth of 15.23% from CNY 5.32 billion year-on-year[9]. - The net profit after deducting non-recurring gains and losses was CNY 5.89 billion, up 17.51% from CNY 5.01 billion in the previous year[9]. - The company achieved total revenue of 63.463 billion yuan, a year-on-year increase of 12.31%, and a net profit of 6.139 billion yuan, up 15.40% from the previous year[22]. - The liquid milk business generated revenue of 42.892 billion yuan, a growth of 1.14%, while the milk powder and dairy products segment saw revenue of 12.071 billion yuan, increasing by 58.28%[22]. - The company reported a net profit of 3,101.01 million RMB for the period, with a registered capital of 18,085.46 million HKD[43]. - The company’s total comprehensive income for the first half of 2022 was CNY 7.46 billion, an increase from CNY 6.43 billion in the first half of 2021[95]. - The company's net profit for the first half of 2022 was ¥7.10 billion, compared to ¥6.29 billion in the same period of 2021, indicating a growth of 12.9%[92]. Assets and Liabilities - The company's total assets increased by 15.91% to CNY 118.19 billion compared to CNY 101.96 billion at the end of the previous year[9]. - The total liabilities amounted to RMB 67.35 billion, up from RMB 53.17 billion, which is an increase of approximately 26.6%[88]. - The company's equity attributable to shareholders decreased slightly to RMB 46.81 billion from RMB 47.71 billion, a decline of about 1.9%[88]. - Short-term borrowings surged to RMB 22.54 billion, compared to RMB 12.60 billion at the beginning of the year, marking an increase of around 79.0%[88]. - The company's total liabilities at the end of the reporting period were approximately CNY 21.07 billion, indicating a manageable debt level[102]. Cash Flow - The company reported a net cash flow from operating activities of CNY 5.53 billion, down 12.74% from CNY 6.34 billion in the same period last year[9]. - The total cash inflow from operating activities for the first half of 2022 was CNY 66.13 billion, an increase of 10.4% compared to CNY 59.60 billion in the same period of 2021[96]. - The net cash flow from investment activities was negative at CNY -9.12 billion, worsening from CNY -3.90 billion in the same period last year[97]. - The ending balance of cash and cash equivalents was CNY 33.49 billion, up from CNY 21.15 billion at the end of the first half of 2021[97]. Research and Development - Research and development expenses increased by 21.04% to ¥307.69 million, driven by the merger with Ausnutria Dairy[30]. - The company is investing approximately $50 million in R&D for new technologies aimed at enhancing product efficiency and sustainability[130]. - The company has implemented a digital transformation strategy to enhance its online and offline channel collaboration, responding effectively to changing consumer demands[15]. Market Expansion and Product Development - International business revenue increased by 58% compared to the same period last year, reflecting successful overseas market expansion[15]. - The company continues to focus on high-growth segments such as organic dairy products and cheese snacks, with these areas growing over 20% year-on-year[15]. - The company launched new products such as AMX 0 sugar strawberry and AMX Xinjiang cantaloupe, which performed well in the market[24]. - The company plans to expand its market presence by entering three new regions by the end of 2023, aiming for a 10% increase in market share[128]. Environmental and Social Responsibility - The company strictly adheres to environmental protection laws and has not experienced any pollution incidents or penalties during the reporting period[50]. - The company has implemented measures to reduce environmental impact, including monitoring of ammonia nitrogen levels[54]. - The company donated a total of CNY 46.8 million in student milk to support children's health and dreams as part of the "Yili Nutrition 2030" initiative[66]. - The company actively responded to natural disasters by providing nutritional supplies to affected areas, including during the Sichuan earthquake and Guangdong floods[67]. Corporate Governance - The company has undergone changes in its board of directors, with Li Feng being elected as a new director[47]. - The company has not faced any major litigation or arbitration matters during the reporting period[69]. - The company has fulfilled all commitments made by its actual controllers and shareholders during the reporting period[68]. Financial Ratios and Performance Metrics - The company's current ratio decreased by 11.21% to 1.03 compared to the previous year-end[86]. - The debt-to-asset ratio increased by 9.28% to 56.99% compared to the previous year-end[86]. - The interest coverage ratio decreased by 17.46% to 13.76 compared to the previous year[86]. Investment and Acquisitions - The acquisition of Ausnutria Dairy led to a significant increase in trading financial assets, which rose by 256.81% to ¥132,779,590.61[34]. - A strategic acquisition of a smaller competitor is anticipated to close by Q4 2022, expected to increase overall revenue by 8%[131]. Compliance and Risk Management - The company has implemented a risk response mechanism to adapt to global pandemic and macroeconomic changes, ensuring timely supply of products and materials[27]. - The company is actively monitoring industry risks related to supply and demand of fresh milk, import raw material prices, and market demand growth[45].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 30,912,906,194.78, representing a year-on-year increase of 13.41%[4] - The net profit attributable to shareholders was CNY 3,519,032,464.86, up 24.32% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 3,290,051,933.91, reflecting a 25.18% increase year-on-year[4] - Total operating revenue for Q1 2022 reached ¥31,047,457,895, an increase of 13.1% compared to ¥27,362,779,682 in Q1 2021[15] - Net profit for Q1 2022 was ¥3,508,015,141, up 24.0% from ¥2,827,235,572 in Q1 2021[16] - The company's operating revenue for Q1 2022 was CNY 29.32 billion, an increase of 12.8% compared to CNY 26.16 billion in Q1 2021[22] - Net profit for Q1 2022 reached CNY 5.97 billion, up 10.4% from CNY 5.41 billion in the same period last year[22] - The company's operating profit was CNY 6.44 billion, representing a growth of 10.5% from CNY 5.83 billion in Q1 2021[22] Earnings and Shareholder Returns - Basic earnings per share for the period were CNY 0.56, an increase of 19.15% year-on-year[4] - Diluted earnings per share were CNY 0.55, reflecting a 17.02% increase compared to the same period last year[4] - Basic earnings per share for Q1 2022 was ¥0.56, compared to ¥0.47 in Q1 2021, reflecting a 19.15% increase[16] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 60.65% to CNY 441,419,296.72 due to a decline in advance payments received[7] - Cash flow from operating activities for Q1 2022 was ¥441,419,297, a decrease from ¥1,121,729,589 in Q1 2021[18] - The company experienced a decrease in cash inflow from operating activities, totaling ¥30,313,329,560 in Q1 2022, compared to ¥27,275,203,003 in Q1 2021[18] - Cash flow from operating activities showed a net outflow of CNY 72.51 million, an improvement from a net outflow of CNY 626.90 million in Q1 2021[23] - The company's cash and cash equivalents at the end of Q1 2022 stood at CNY 20.05 billion, down from CNY 13.66 billion at the end of Q1 2021[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 122,018,177,742.67, an increase of 19.67% from the end of the previous year[4] - As of March 31, 2022, the total current assets amounted to RMB 60,868,854,895.39, an increase from RMB 50,154,959,896.68 as of December 31, 2021, representing a growth of approximately 21.4%[13] - The total non-current assets reached RMB 61,149,322,847.28, up from RMB 51,807,379,945.97, indicating an increase of about 17.5%[13] - The company's total liabilities reached RMB 66,780,929,841.24, up from RMB 53,171,321,535.65, which is an increase of about 25.6%[14] - Total current liabilities increased to RMB 54,687,265,725.33 from RMB 43,296,239,436.14, marking an increase of around 26.3%[14] Investments and Other Income - The company reported non-recurring gains of CNY 228,980,530.95 after tax, primarily from government subsidies and other non-operating income[6] - The company announced an investment in acquiring a stake in Ausnutria Dairy Corporation Ltd., holding 1,070,113,149 shares, which is about 59.17% of the total issued shares[12] Expenses - Total operating costs for Q1 2022 were ¥27,134,288,292, representing a 11.4% increase from ¥24,287,046,977 in Q1 2021[15] - Research and development expenses for Q1 2022 amounted to ¥115,763,446, an increase from ¥103,808,741 in Q1 2021[15] - Sales expenses for Q1 2022 were ¥5,633,273,617, up from ¥4,641,055,832 in Q1 2021, indicating a 21.4% increase[15] Comprehensive Income - The company reported a total comprehensive income of ¥3,424,708,494 for Q1 2022, an increase from ¥2,626,784,545 in Q1 2021[16] - The total comprehensive income for Q1 2022 was CNY 5.95 billion, compared to CNY 5.39 billion in the same quarter of the previous year[22]

Financial Performance - The company achieved a net profit of ¥8,404,397,634.37 for the year 2021, with a total distributable profit of ¥16,806,145,133.99 at the end of the reporting period[3]. - The company's operating revenue for 2021 was ¥110.14 billion, an increase of 14.11% compared to ¥96.52 billion in 2020[12]. - Net profit attributable to shareholders for 2021 reached ¥8.70 billion, reflecting a growth of 22.98% from ¥7.08 billion in 2020[12]. - The net cash flow from operating activities significantly increased by 57.61% to ¥15.53 billion, compared to ¥9.85 billion in 2020[12]. - The total assets at the end of 2021 were ¥101.96 billion, up 43.30% from ¥71.15 billion at the end of 2020[12]. - The weighted average return on equity for 2021 was 25.59%, a slight increase of 0.41 percentage points from 25.18% in 2020[12]. - The basic earnings per share for 2021 was ¥1.43, representing a 22.22% increase from ¥1.17 in 2020[12]. - The company achieved total revenue of CNY 110.595 billion, a year-on-year increase of 14.15%, and a net profit of CNY 8.732 billion, up 23.00% compared to the previous year[28]. - The company reported a net profit of CNY 9,800 thousand from Yili Financial Co., Ltd.[69]. - The company reported a net profit of approximately 8.70 billion RMB for 2021, which is a substantial increase compared to the previous year's profit[186]. Dividend Policy - A cash dividend of ¥9.60 per 10 shares (including tax) is proposed, amounting to a total of ¥6,144,125,681.28, which represents 70.58% of the net profit attributable to shareholders for 2021[3]. - The company has maintained a consistent dividend policy, reflecting its commitment to returning value to shareholders[3]. - The company has a clear cash dividend policy that aligns with its articles of association and shareholder resolutions, ensuring the protection of minority shareholders' rights[106]. - The company maintained a positive profit distribution plan, ensuring that profits are allocated in accordance with established guidelines and shareholder expectations[105]. Market Expansion and Product Development - The company plans to continue its market expansion and product development strategies in the upcoming year[4]. - The company is focused on expanding its market presence through strategic acquisitions and partnerships[1]. - The company plans to invest 14.802 billion CNY in leading industry projects and supporting projects in 2022[76]. - The company aims to maintain a strong financial position while pursuing growth opportunities in the market[145]. - The company is focused on optimizing its capital structure and improving its financial metrics in the coming years[145]. Research and Development - The company increased its R&D expenses by 23.39% to ¥601 million, reflecting a commitment to product innovation and development[38]. - The company has established a comprehensive innovation mechanism across raw materials, formulas, processes, efficacy, and packaging, focusing on consumer health nutrition needs[33]. - The company has 21,072 production personnel, 18,352 sales personnel, and 12,505 technical personnel among its employees[100]. - The company has a total of 57 doctoral graduates and 1,467 master's graduates in its workforce[100]. - Research and development expenses for 2021 were RMB 601.02 million, up from RMB 487.10 million, indicating a growth of 23.3%[176]. Environmental Responsibility - The company has committed to carbon neutrality and has conducted carbon footprint calculations for all its factories, contributing to the UN's first "Corporate Carbon Neutral Pathway" white paper[127]. - The company invested a total of 120 million yuan in environmental protection measures in 2021, focusing on upgrading online monitoring equipment and pollution treatment systems[119]. - The company has established real-time monitoring systems for emissions, ensuring compliance with local ecological environment department requirements[119]. - The company has successfully transformed the operation method of 22 wastewater treatment plants to reduce sludge production by 17,700 tons[124]. - The company has implemented pollution prevention facilities in accordance with the "three simultaneous" requirements for design, construction, and operation[119]. Governance and Compliance - The company has established a governance structure with a board of directors consisting of 11 members, including 4 independent directors[79]. - The company has implemented a comprehensive internal control management system, enhancing decision-making efficiency and ensuring compliance with legal regulations[109]. - The company has not reported any significant internal control deficiencies during the reporting period, indicating robust management practices[110]. - The company has established various governance policies, including the Independent Director System and the Related Party Transaction Management System, to strengthen institutional frameworks and protect investor rights[113]. - The company has engaged in no significant related party transactions that require disclosure, maintaining transparency in its operations[136]. Strategic Acquisitions - The company expanded its market presence through the acquisition of China Zhongdi Dairy Holdings Co., Ltd. and other strategic investments[56]. - The company has acquired China Zhongdi Dairy Holdings Limited, which has a net asset of CNY 266,577.86 thousand[70]. - The company acquired two new subsidiaries, China Zhongdi Dairy Holdings Co., Ltd. and 49 (Shanghai) Trading Co., Ltd., and has successfully integrated their operations, ensuring smooth daily management[111]. Financial Stability - The company’s total assets increased, with cash and cash equivalents representing 31.13% of total assets at the end of the reporting period[58]. - The total liabilities amounted to CNY 53.17 billion, up from CNY 40.62 billion, which is an increase of approximately 31.0%[173]. - The company's equity attributable to shareholders reached CNY 47.71 billion, compared to CNY 30.38 billion in the previous year, representing a growth of about 56.9%[173]. - The company reported a significant increase in deferred income due to government funding for research projects[61]. - The company has no overdue bonds, indicating a stable debt repayment situation[159]. Social Responsibility - The company has actively participated in social responsibility initiatives, contributing to public health and disaster relief efforts across multiple provinces[132]. - The company has provided financing support of approximately 7.596 billion yuan to cooperative pastures to enhance the dairy industry's development[130]. - The company has invested 7.1834 million yuan in cash and student milk donations, benefiting nearly 60,000 children through its "Yili Nutrition 2030" initiative[131]. Risk Management - The company has disclosed potential risks in the report, urging investors to maintain awareness of the differences between plans, forecasts, and commitments[4]. - The company faces uncertainties related to industry risks, including supply and demand for fresh milk and international market expansion[77]. - The company has allocated approximately 151.88 million RMB to general risk reserves, indicating a proactive approach to risk management[185].